IND approval
Scope
Date
~
-
Bio & Pharma
Celltrion establishes subsidiary in Vietnam
Celltrion Inc., South Korea’s largest biosimilar maker, said on Monday that it completed the establishment of a local subsidiary in Vietnam....
Sep 30, 2024 (Gmt+09:00)
-
Business & Politics
South Korea scraps anti-nuclear policy with approval of two nuclear plants
South Korea has approved the construction of two nuclear power plants, officially ending its anti-nuclear policy pursued by the previous Moon Jae-in...
Sep 13, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
SK Innovation-SK E&S merger gains shareholders’ nod
SK Innovation Co., South Korea’s largest energy company, has won majority support from its shareholders for a merger with its liquefied natura...
Aug 27, 2024 (Gmt+09:00)
-
Aerospace & Defense
South Korea to extend export missile range from 300 km to 500 km
South Korea has decided to extend the range of missiles for export to 500 kilometers from the current 300 km after accepting requests to do so from ...
Aug 20, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets approval of Steqeyma in Canada
South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Steqeyma, a biosimilar of the autoimmune dise...
Jul 31, 2024 (Gmt+09:00)
-
Food & Beverage
Lotte India, Havmor to merge to raise $722.4 mn in sales
South Korean confectionery giant Lotte Wellfood Co. will merge its Indian subsidiaries — Lotte India Co. and Havmor Ice Cream Pvt — to b...
Jul 30, 2024 (Gmt+09:00)
-
Corporate restructuring
Doosan Robotics, Bobcat merger prompts call for law revision
Doosan Group’s announcement of a merger between Doosan Robotics Inc. and Doosan Bobcat Inc. has met with strong criticism from investors and p...
Jul 22, 2024 (Gmt+09:00)
-
Shipping & Shipbuilding
Korea approves HD KSOE-STX Heavy merger with conditions
South Korea’s antitrust body has given a conditional nod to leading domestic shipyard HD Korea Shipbuilding & Offshore Engineering Co.'s (...
Jul 15, 2024 (Gmt+09:00)
-
Aerospace & Defense
S.Korea’s Hanwha, Doosan to develop fighter jet engines
Hanwha Aerospace Co., South Korea’s top defense manufacturer, and Doosan Enerbility Co., a major local power plant builder, are set to develop...
Jul 02, 2024 (Gmt+09:00)
-
Electronics
Solus to supply copper foil for AI accelerators to Nvidia
Solus Advanced Materials, a South Korean copper foil supplier, will provide copper foil for AI accelerators to Nvidia, a leading company in artifici...
Jul 01, 2024 (Gmt+09:00)
-
IPOs
Kosdaq cancels IPO approval for cloud developer InnoGrid
The Kosdaq market under the Korea Exchange said on Wednesday it has canceled its preliminary approval for InnoGrid Co.’s initial public offeri...
Jun 19, 2024 (Gmt+09:00)
-
Shipping & Shipbuilding
Hanwha Ocean gets approval for LCO2 carrier from ABS
South Korea's Hanwha Ocean Co. said on Thursday it received Approval in Principle (AIP) from classification society ABS for a 40,000 cubic meter liq...
Jun 07, 2024 (Gmt+09:00)
-
Airlines
Korean Air expects US approval for Asiana merger by end-Oct: report
Korean Air Lines Co., South Korea’s No. 1 full-service carrier, expects to gain full approval from the US government by the end of October to ...
Jun 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Investors dump Korean biotech HLB stocks on FDA rejection
HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...
May 17, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets OK to sell Stelara biosimilar in Europe
South Korea's Samsung Bioepis has received approval from the European Commission to sell Pyzchiva, a biosimilar of the autoimmune disease Stelara.&n...
Apr 23, 2024 (Gmt+09:00)
-
Corporate restructuring
Hanwha Aerospace to spin off non-core units to focus on defense business
Hanwha Aerospace Co., South Korea’s answer to Elon Musk’s SpaceX, is spinning off its non-core units to focus on defense and aerospace b...
Apr 03, 2024 (Gmt+09:00)
-
Entertainment
K Enter moves step closer to Nasdaq listing in May
K Enter Holdings Inc., an umbrella entity of South Korea-based entertainment companies creating original entertainment content and managing related ...
Mar 27, 2024 (Gmt+09:00)
-
Artificial intelligence
Lunit gets court approval for Volpara acquisition in New Zealand
South Korean medical AI company Lunit announced on Thursday that it received the first approval from the High Court of New Zealand for its plan to a...
Mar 14, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Airlines
Japan approves Korean Air-Asiana merger
Japan has finally given the nod to the merger between South Korea’s No. 1 full-service carrier Korean Air Lines Co. and No. 2 Asiana Airlines ...
Jan 31, 2024 (Gmt+09:00)
-
Banking & Finance
S.Korea’s LS Group wins regulatory nod for securities biz
South Korea’s electrics components-to-energy conglomerate LS Group is set to start the securities business as it secured regulatory approval t...
Jan 18, 2024 (Gmt+09:00)
-
Corporate restructuring
Taeyoung becomes 1st Korean builder in debt workout in decade
The vast majority of creditors to Taeyoung Engineering & Construction Co. (Taeyoung E&C) have agreed to start debt restructuring for the tro...
Jan 12, 2024 (Gmt+09:00)
-
Bio & Pharma
CGBio gets FDA approval for Novosis Putty
South Korea's bio-regenerative medical firm CGBio announced on Tuesday that its Novosis Putty has been designated as a breakthrough device by the US...
Jan 02, 2024 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval of Xolair biosimilar in Canada
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has applied for CT-P39, a biosimilar of the treatment of asth...
Dec 27, 2023 (Gmt+09:00)
-
Bio & Pharma
J&J seeks US, European approval for drug developed with Yuhan
Global healthcare giant Johnson & Johnson is seeking approval for a lung cancer drug developed with Yuhan Corp., bringing the South Korean pha...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
NGeneBio gets approval for cancer diagnostic device in Thailand
South Korean medical diagnostic company NGeneBio Co. announced on Friday that it has received approval for the sale of its in-vitro diagnostic medic...
Dec 22, 2023 (Gmt+09:00)
-
Bio & Pharma
ToolGen gets FDA approval for TGT-001 as ODD
South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...
Dec 18, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma gets FDA approval for Alyglo
South Korea’s GC Biopharma Corp. announced on Monday that it received approval from the US Food and Drug Administration (FDA) for the immuno...
Dec 18, 2023 (Gmt+09:00)
-
Private equity
China's CICC enters S.Korea with its private equity fund
BEIJING – CICC Capital, a unit of China International Capital Corp. (CICC), has entered the South Korean market with the launch of a private e...
Dec 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
Latest News
- 1 Hyundai, Waymo forge multi-year, strategic partnership for self-driving vehicles
- 2 AI startup MarqVision raises $16.5 mn to close Series A
- 3 Taihan Cable wins $630 mn power grid project in Singapore
- 4 Korean startup scene is gloomy, say 2 out of 5 startup CEOs
- 5 MBK ups stakes for Korea Zinc to match buyback offer